Last issue we did GLP-1s and muscle. This week, the messiest topic in this whole space: peptides and the law. There's a real date on the calendar that matters, and most of the noise online about it is wrong in one direction or the other. Let me untangle it.
Deep Dive: The peptide gray market's big week
If you've spent any time in this world you know peptides live in a weird legal fog. BPC-157, TB-500, the GH-releasing stuff. People run them, clinics prescribe them, and the regulatory status has been genuinely unclear. That fog is starting to lift, and the direction matters whether you use these or just want to understand the landscape. Here's the actual timeline, because the internet keeps mangling it.
What already happened. In September 2023, the FDA placed BPC-157 (and several other peptides) on its Category 2 list under the interim compounding policy. Category 2 meant compounding pharmacies couldn't legally use it. That's the rule that pushed a lot of this underground. Then in April 2026, the FDA removed BPC-157 from Category 2. 🟢 Strong evidence: documented regulatory action, not a rumor.
The crucial thing removal does NOT mean. Off Category 2 is not the same as FDA approved. BPC-157 is still an unapproved, investigational compound. Removal just means it's no longer automatically barred from compounding. Approval and "legal to compound" are two different doors. Anyone telling you BPC-157 is now "FDA approved" is wrong. 🟢 Strong evidence.
The date that matters: July 23-24. The Pharmacy Compounding Advisory Committee meets to review seven restricted peptides, including BPC-157 and TB-500, and recommend whether they belong on the list licensed pharmacies can legally compound from. If the committee says yes and the FDA follows, you'd be able to get these through a licensed pharmacy with a prescription instead of a sketchy website. If they say no, it stays gray. 🟡 Moderate evidence: the meeting is scheduled, the outcome isn't decided yet.
Why you should care even if you never touch a peptide. This is the difference between a physician-supervised, quality-controlled supply and a "research chemical" bought from a vendor with a disclaimer and zero oversight. Legal compounding means dosing you can trust and a doctor in the loop. That's strictly safer than the status quo. 🟡 Moderate evidence on the safety upside, it depends on the committee's call.
My read: mark July 23-24. If it goes the way a lot of people expect, the smart move is to get these into a real clinical relationship, not to keep gambling on gray-market purity. And a reminder I'll repeat forever: this newsletter will never point you at a vendor. Coverage of the landscape, yes. A link to buy, never. That's not me being cautious for fun, it's the line that keeps this thing alive.
Not medical advice, and definitely not a nudge to run anything. Talk to a doctor who actually knows this area.
Quick Hits
The single best predictor of how long you'll live isn't your cholesterol. In a Cleveland Clinic study of 122,000 adults (JAMA Network Open, 2018), low cardiorespiratory fitness carried a mortality risk on par with or greater than smoking, diabetes, or coronary disease, and there was no ceiling: the fittest lived longest, full stop. Separately, the classic fitness data peg every ~1 MET gain at roughly 13-15% lower mortality risk. Translation: the zone 2 cardio you keep skipping is the highest-leverage thing you can do. 🟢 Strong evidence
The protein-per-meal number that actually matters. It's not just daily total. To reliably trigger muscle protein synthesis after 40 you want about 25-30g of quality protein per meal, enough to clear roughly 2.5-3g of leucine. Below that threshold the muscle-building switch doesn't fully flip. Spreading protein across meals beats backloading it all at dinner. 🟡 Moderate evidence
Lifting beats the supplement, again. A 2025 GeroScience trial in older women found resistance training raised muscle protein synthesis and reversed frailty markers, while leucine supplementation alone did not. The pills are a rounding error next to the barbell. 🟡 Moderate evidence
The FDA is cracking down on telehealth GLP-1 hype. 30-plus warning letters went out to telehealth companies over misleading claims about compounded GLP-1s. If an online clinic's marketing sounds too good, that's now an official red flag, not just a vibe. ⚪ Regulatory
My Experience
Real talk, since this one's about peptides and the law. I've run a lot of these over the years, most of the usual list, and I want to be honest about what that actually involves. Every gray-market order is the same quiet gamble: you don't really know what's in the vial. Underdosed, overdosed, mislabeled, or cut with something that has no business near your bloodstream. And this isn't me being dramatic. When the US Anti-Doping Agency tested black-market peptides, more than 20% came back mislabeled or contaminated, and independent labs have found samples ranging from nearly pure to almost none of the actual compound, a few even carrying heavy metals like arsenic and lead. The "Certificate of Analysis" on a lot of these sites is worth about what you'd expect from a PDF made by the same guy selling you the vial.
So you become the quality-control department. You're the lab, the test subject, and the man squinting at his own bloodwork three months later trying to reverse-engineer what he actually took. I made my peace with that risk because the upside was worth it to me. But I shouldn't have had to, and neither should you.
That's the whole reason July 23-24 matters to me. Legal compounding means a licensed pharmacy, real quality control, and a doctor in the loop instead of a stranger, a disclaimer, and a website mascot. The compound stops being the scariest variable in the experiment. I'm betting it goes that way. We'll know on the 24th.
My protocol, my body, my doctors. Not a template.
Next issue (Tuesday): the one that's personal for me. Is TRT actually safe for your heart? I read the 5,200-man trial, the reassuring headline and the fine print nobody quotes, so you don't have to.
The 40+ Protocol is educational content, not medical advice. I'm a game designer reporting studies and my own n=1 experiments, not a doctor. Talk to yours before changing anything. No affiliate links in this issue.